Medtronic (NYSE:MDT) announced today that its PulseSelect pulsed-field ablation (PFA) system exceeded its safety performance goal in a clinical trial. PulseSelect registered an adverse event rate of 0.7%. Medtronic said that marks one of the lowest adverse event rates of any previous FDA investigational device exemption (IDE) trial for AFib ablation or any multi-center PFA […]
Medtronic
Data backs durability of Medtronic CoreValve Evolut TAVR
Medtronic (NYSE:MDT) today announced five-year data that supports its CoreValve Evolut transcatheter aortic valve replacement (TAVR) implant. Dr. Steven Yakubov presented findings at the 2023 annual meeting of Cardiovascular Research Technologies (CRT 2023). The data showed significantly better valve performance and durability compared to surgical aortic valve replacement (SAVR). Medtronic’s study evaluated bioprosthetic valve dysfunction […]
Study backs Medtronic next-gen MiniMed 780G insulin pump for type 1 diabetes
Medtronic announced today that one-year data backs the use of its next-generation MiniMed 780G automated insulin pump. The ADAPT study compared MiniMed 780 G against multiple daily injections of insulin with an intermittently scanned CGM. ADAPT, which included 82 subjects, marks the first multi-national, randomized controlled study comparing these methods. The study evaluated adults (18 […]
Medtronic relaunches Harmony transcatheter pulmonary valve system
Medtronic (NYSE:MDT) announced today that it relaunched its Harmony transcatheter pulmonary valve (TPV) system. The non-surgical heart valve for treating severe pulmonary valve regurgitation first received FDA clearance in March 2021. It treats congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). Harmony provides a minimally invasive alternative for patients […]
Medtronic TAVR, Micra and spine tech drive Q3 earnings beat
Medtronic (NYSE: MDT) today announced Street-beating third-quarter results, upping its full-year guidance amid continued momentum. However, company officials also said that they have initiated significant expense reductions amid macroeconomic pressures, including a strong dollar and inflation. The medtech giant’s next-gen Evolut FX TAVR system, fully launched in the U.S. in September 2022, helped drive the […]
Medtronic wins CE mark for extravascular defibrillator system
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Aurora EV-ICD and Epsila EV MRI SureScan system. The Aurora EV-ICD and Epsila EV defibrillation lead treat dangerously fast heart rhythms that can lead to sudden cardiac arrest. The EV-ICD (extravascular implantable cardioverter-defibrillator) system offers the live-saving benefits of traditional ICDs. However, it […]
Medtronic faces antitrust lawsuit over surgical devices
Applied Medical Resources is accusing Medtronic (NYSE:MDT) of using its size to shut down competition in the U.S. market for advanced bipolar devices used to cut tissue and seal blood vessels. Rancho Santa Margarita, California–based Applied Medical filed an antitrust complaint yesterday in Central California’s U.S. District Court. “We are proud to be a leader […]
Apple hires Medtronic Chief Human Resources Officer Carol Surface
Medtronic (NYSE:MDT) EVP and Chief Human Resources Officer Carol Surface will become the first chief people officer at Apple (Nasdaq:APPL) in March. That’s according to Bloomberg, which reported that Apple CEO Tim Cook disclosed the new hire in a memo to employees. Surface joined Medtronic — the world’s largest medical device company — in 2013 […]
Medtronic hit with $106.5M verdict in CoreValve TAVI patent case
Medtronic (NYSE:MDT) must pay $106.5 million in a TAVI patent infringement lawsuit, a federal jury in California ruled this week. Colibri Heart Valve claimed in 2019 that Medtronic violated its patents for replacement heart valves. The lawsuit alleged infringement of two patents with the Medtronic CoreValve, CoreValve Evolut R, CoreValve Evolut Pro, and CoreValve Evolut […]
Medtronic: Linq monitor boosts AFib detection 10-fold among stroke patients
Medtronic (NYSE:MDT) today announced clinical data demonstrating significant improvements in AFib detection using the Reveal Linq. The study compared the Reveal Linq insertable cardiac monitor (ICM) to patients randomized to standard of care. Those patients did not receive continuous long-term monitoring. Medtronic presented the three-year data at the American Stroke Association’s International Stroke Conference (ISC) […]
The year ahead in diabetes care: what to expect in 2023
After a banner year for diabetes technology in 2022, there’s still plenty to look forward to in 2023. Throughout 2022, we saw a wide range of advancements in diabetes technology. We saw launches for next-generation technologies, exciting clinical trial results, rumored spinouts and acquisitions and more. You can read all about the biggest diabetes stories […]
